Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

Blenrep

Australian Public Assessment Report

AusPAR

AusPAR Blenrep [PDF, 1.55 MB]

AusPAR Blenrep [DOCX, 4.3 MB]

Attachment Product information for Blenrep [PDF, 767.24 KB]

Attachment Product information for Blenrep [DOCX, 562.62 KB]

Device/Product Name

Blenrep

Active ingredients

Belantamab mafodotin

AusPAR Date

4 May 2026

Published

4 May 2026

Submission Number

PM-2024-04725-1-4

Submission Type

New chemical entity

Decision

Approved

Product types

Prescription medicines